CXCL10 and neoplasm: Consistent with our observations, Barash et al. indicated that CXCL10 administration not only induced the infiltration of T cells and NK cells into myeloma tumors but also reduced the accumulation of Treg cells at the tumor site, thereby suppressing tumor progression (57).